Awareness and Knowledge of Antimicrobial Resistance, Antimicrobial Stewardship and Barriers to Implementing Antimicrobial Susceptibility Testing among Medical Laboratory Scientists in Nigeria: A Cross-Sectional Study
Abstract
:1. Introduction
2. Methods
2.1. Study Population and Sample Size Calculation
2.2. Questionnaire Design and Administration
2.3. Ethical Considerations
2.4. Data Management and Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
References
- O’Neill, J. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations; HM Government and the Wellcome Trust: London, UK, 2016. Available online: https://apo.org.au/node/63983 (accessed on 11 January 2023).
- Lamikanra, A.; Crowe, J.L.; Lijek, R.S.; Odetoyin, B.W.; Wain, J.; Aboderin, A.O.; Okeke, I.N. Rapid evolution of fluoroquinolone-resistant Escherichia coli in Nigeria is temporally associated with fluoroquinolone use. BMC Infect. Dis. 2011, 11, 1–10. [Google Scholar] [CrossRef] [PubMed]
- Murray, C.J.; Ikuta, K.S.; Sharara, F.; Swetschinski, L.; Aguilar, G.R.; Gray, A.; Han, C.; Bisignano, C.; Rao, P.; Wool, E.; et al. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet 2022, 399, 629–655. [Google Scholar] [CrossRef] [PubMed]
- Martínez, J.L. Antibiotics and antibiotic resistance genes in natural environments. Science 2008, 321, 365–367. [Google Scholar] [CrossRef] [PubMed]
- Brinkac, L.; Voorhies, A.; Gomez, A.; Nelson, K.E. The threat of antimicrobial resistance on the human microbiome. Microb. Ecol. 2017, 74, 1001–1008. [Google Scholar] [CrossRef]
- Majumder, M.A.A.; Rahman, S.; Cohall, D.; Bharatha, A.; Singh, K.; Haque, M.; Gittens-St Hilaire, M. Antimicrobial stewardship: Fighting antimicrobial resistance and protecting global public health. Infect. Drug Resist. 2020, 13, 4713–4738. [Google Scholar] [CrossRef] [PubMed]
- Tello, A.; Austin, B.; Telfer, T.C. Selective pressure of antibiotic pollution on bacteria of importance to public health. Environ. Health Perspect. 2012, 120, 1100–1106. [Google Scholar] [CrossRef]
- Endashaw Hareru, H.; Sisay, D.; Kassaw, C.; Kassa, R. Antibiotics non-adherence and its associated factors among households in southern Ethiopia. SAGE Open Med. 2022, 10, 20503121221090472. [Google Scholar]
- World Health Organisation. Antibiotic Resistance; WHO: Geneva, Switzerland, 2020; Available online: https://www.who.int/news-room/fact-sheets/detail/antibioticresistance (accessed on 22 March 2022).
- Naing, L.; Winn, T.B.N.R.; Rusli, B.N. Practical issues in calculating the sample size for prevalence studies. Arch. Orofac. Sci. 2006, 1, 9–14. [Google Scholar]
- Rice, L.B. Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones. In Mayo Clinic Proceedings; Elsevier: Amsterdam, The Netherlands, 2012; Volume 87, pp. 198–208. [Google Scholar]
- Bax, B.D.; Murshudov, G.; Maxwell, A.; Germe, T. DNA topoisomerase inhibitors: Trapping a DNA-cleaving machine in motion. J. Mol. Biol. 2019, 431, 3427–3449. [Google Scholar] [CrossRef]
- Hooper, D.C.; Jacoby, G.A. Topoisomerase inhibitors: Fluoroquinolone mechanisms of action and resistance. Cold Spring Harb. Perspect. Med. 2016, 6, a025320. [Google Scholar] [CrossRef]
- Schroeder, M.R.; Stephens, D.S. Macrolide resistance in Streptococcus pneumoniae. Front. Cell. Infect. Microbiol. 2016, 6, 98. [Google Scholar] [CrossRef] [PubMed]
- Krause, K.M.; Serio, A.W.; Kane, T.R.; Connolly, L.E. Aminoglycosides: An overview. Cold Spring Harb. Perspect. Med. 2016, 6, a027029. [Google Scholar] [PubMed]
- Cushnie, T.T.; O’Driscoll, N.H.; Lamb, A.J. Morphological and ultrastructural changes in bacterial cells as an indicator of antibacterial mechanism of action. Cell. Mol. Life Sci. 2016, 73, 4471–4492. [Google Scholar] [PubMed]
- Lobanovska, M.; Pilla, G. Focus: Drug development: Penicillin’s discovery and antibiotic resistance: Lessons for the future? Yale J. Biol. Med. 2017, 90, 135. [Google Scholar] [PubMed]
- Vázquez-Laslop, N.; Mankin, A.S. How macrolide antibiotics work. Trends Biochem. Sci. 2018, 43, 668–684. [Google Scholar] [CrossRef] [PubMed]
- Miyachiro, M.M.; Contreras-Martel, C.; Dessen, A. Penicillin-binding proteins (PBPs) and bacterial cell wall elongation complexes. In Macromolecular Protein Complexes II: Structure and Function; Springer: Berlin/Heidelberg, Germany, 2019; pp. 273–289. [Google Scholar]
- Eyler, R.F.; Shvets, K. Clinical pharmacology of antibiotics. Clin. J. Am. Soc. Nephrol. 2019, 14, 1080–1090. [Google Scholar] [CrossRef]
- Holmes, A.H.; Moore, L.S.; Sundsfjord, A.; Steinbakk, M.; Regmi, S.; Karkey, A.; Guerin, P.J.; Piddock, L.J. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet 2016, 387, 176–187. [Google Scholar] [CrossRef]
- Tomson, G.; Vlad, I. The need to look at antibiotic resistance from a health systems perspective. Upsala J. Med. Sci. 2014, 119, 117–124. [Google Scholar] [CrossRef]
- Manyi-Loh, C.; Mamphweli, S.; Meyer, E.; Okoh, A. Antibiotic use in agriculture and its consequential resistance in environmental sources: Potential public health implications. Molecules 2018, 23, 795. [Google Scholar] [CrossRef]
- Hutchings, M.I.; Truman, A.W.; Wilkinson, B. Antibiotics: Past, present and future. Curr. Opin. Microbiol. 2019, 51, 72–80. [Google Scholar] [CrossRef]
- Carlet, J.; Collignon, P.; Goldmann, D.; Goossens, H.; Gyssens, I.C.; Harbarth, S.; Jarlier, V.; Levy, S.B.; N’Doye, B.; Pittet, D.; et al. Society’s failure to protect a precious resource: Antibiotics. Lancet 2011, 378, 369–371. [Google Scholar] [CrossRef] [PubMed]
- Ghebremedhin, B.; Olugbosi, M.O.; Raji, A.M.; Layer, F.; Bakare, R.A.; Konig, B.; Konig, W. Emergence of a community-associated methicillin-resistant Staphylococcus aureus strain with a unique resistance profile in Southwest Nigeria. J. Clin. Microbiol. 2009, 47, 2975–2980. [Google Scholar] [CrossRef] [PubMed]
- Ahiarakwem, I.I.E.; Ekejindu, I.M.; Akujobi, C.N.; Aghanya, I.N. Multidrug-Resistant Tuberculosis in Imo State, Southeast, Nigeria. Niger. J. Clin. Pract. 2020, 23, 1172–1177. [Google Scholar]
- Okesola, A.O.; Oni, A.A. Antimicrobial resistance among common bacterial pathogens in South Western Nigeria. Am. -Eurasian J. Agric. Environ. Sci. 2009, 5, 327–330. [Google Scholar]
- Abubakar, U.; Sulaiman, S.A. Prevalence, trend and antimicrobial susceptibility of Methicillin Resistant Staphylococcus aureus in Nigeria: A systematic review. J. Infect. Public Health 2018, 11, 763–770. [Google Scholar] [CrossRef]
- Fadare, J.O.; Ogunleye, O.; Iliyasu, G.; Adeoti, A.; Schellack, N.; Engler, D.; Massele, A.; Godman, B. Status of antimicrobial stewardship programmes in Nigerian tertiary healthcare facilities: Findings and implications. J. Glob. Antimicrob. Resist. 2019, 17, 132–136. [Google Scholar] [CrossRef] [PubMed]
- Chukwu, E.E.; Oladele, D.A.; Awoderu, O.B.; Afocha, E.E.; Lawal, R.G.; Abdus-Salam, I.; Ogunsola, F.T.; Audu, R.A. A national survey of public awareness of antimicrobial resistance in Nigeria. Antimicrob. Resist. Infect. Control. 2020, 9, 1–10. [Google Scholar] [CrossRef] [PubMed]
- Abubakar, U.; Tangiisuran, B. Nationwide survey of pharmacists’ involvement in antimicrobial stewardship programs in Nigerian tertiary hospitals. J. Glob. Antimicrob. Resist. 2020, 21, 148–153. [Google Scholar] [CrossRef]
- Igbeneghu, O.A. Knowledge and practices in the use of antibiotics among a group of Nigerian university students. Int. J. Infect. Control. 2013, 9. [Google Scholar] [CrossRef]
- Auta, A.; Banwat, S.B.; David, S.; Dangiwa, D.A.; Ogbole, E.; Tor-anyiin, A.J. Antibiotic use in some Nigerian communities: Knowledge and attitudes of consumers. Trop. J. Pharm. Res. 2013, 12, 1087–1092. [Google Scholar] [CrossRef]
- Ekwochi, U.; Chinawa, J.M.; Osuorah, C.D.; Odetunde, O.I.; Obu, H.A.; Agwu, S. The use of unprescribed antibiotics in management of upper respiratory tract infection in children in Enugu, South East Nigeria. J. Trop. Pediatr. 2014, 60, 249–252. [Google Scholar] [CrossRef] [PubMed]
- Joseph, F.; Oladele, O.; Oludare, O.; Olatunde, O. Drug prescribing pattern for under-fives in a paediatric clinic in South-Western Nigeria. Ethiop. J. Health Sci. 2015, 25, 73–78. [Google Scholar] [CrossRef] [PubMed]
- Abubakar, U.; Syed Sulaiman, S.A.; Adesiyun, A.G. Utilization of surgical antibiotic prophylaxis for obstetrics and gynaecology surgeries in Northern Nigeria. Int. J. Clin. Pharm. 2018, 40, 1037–1043. [Google Scholar] [CrossRef] [PubMed]
- Srinivasan, A. Antibiotic stewardship: Why we must, how we can. Clevel. Clin. J. Med. 2017, 84, 673. [Google Scholar] [CrossRef] [PubMed]
- Leekha, S.; Terrell, C.L.; Edson, R.S. General principles of antimicrobial therapy. In Mayo Clinic Proceedings; Elsevier: Amsterdam, The Netherlands, 2011; Volume 86, pp. 156–167. [Google Scholar]
- World Health Organization. Diagnostic Stewardship: A Guide to Implementation in Antimicrobial Resistance Surveillance Sites; World Health Organization: Geneva, Switzerland, 2016; Available online: https://apps.who.int/iris/handle/10665/251553 (accessed on 12 March 2023).
- Morgan, D.J.; Malani, P.; Diekema, D.J. Diagnostic stewardship—Leveraging the laboratory to improve antimicrobial use. JAMA 2017, 318, 607–608. [Google Scholar] [CrossRef] [PubMed]
- Rolfe, R.; Kwobah, C.; Muro, F.; Ruwanpathirana, A.; Lyamuya, F.; Bodinayake, C.; Nagahawatte, A.; Piyasiri, B.; Sheng, T.; Bollinger, J.; et al. Barriers to implementing antimicrobial stewardship programs in three low-and middle-income country tertiary care settings: Findings from a multi-site qualitative study. Antimicrob. Resist. Infect. Control. 2021, 10, 1–11. [Google Scholar] [CrossRef] [PubMed]
- MacDougall, C.; Polk, R.E. Antimicrobial stewardship programs in health care systems. Clin. Microbiol. Rev. 2005, 18, 638–656. [Google Scholar] [CrossRef] [PubMed]
- Messacar, K.; Parker, S.K.; Todd, J.K.; Dominguez, S.R. Implementation of rapid molecular infectious disease diagnostics: The role of diagnostic and antimicrobial stewardship. J. Clin. Microbiol. 2017, 55, 715–723. [Google Scholar] [CrossRef]
- World Health Organization. Antibiotic Resistance: Multi-Country Public Awareness Survey; World Health Organization: Geneva, Switzerland, 2015; Available online: https://apps.who.int/iris/handle/10665/194460 (accessed on 12 January 2021).
- Alex, I.O. Knowledge of antibiotic use and resistance among students of a medical school in Nigeria. Malawi Med. J. 2019, 31, 133–137. [Google Scholar] [CrossRef]
- Nigeria Centre for Disease Control. Antimicrobial Use and Resistance in Nigeria: Situation Analysis and Recommendations. 2017. Available online: https://ncdc.gov.ng/themes/common/docs/protocols/77_1511368219.pdf (accessed on 12 January 2021).
- Wu, M.J.; Zhao, K.; Fils-Aime, F. Response rates of online surveys in published research: A meta-analysis. Comput. Hum. Behav. Rep. 2022, 7, 100206. [Google Scholar] [CrossRef]
- Archer, T. Characteristics associated with increasing the response rates of web-based surveys. Pract. Assess. Res. Eval. 2007, 12, 12. [Google Scholar]
- Shih, T.H.; Fan, X. Comparing response rates from web and mail surveys: A meta-analysis. Field Methods 2008, 20, 249–271. [Google Scholar] [CrossRef]
- Cook, C.; Heath, F.; Thompson, R.L. A meta-analysis of response rates in web-or internet-based surveys. Educ. Psychol. Meas. 2000, 60, 821–836. [Google Scholar] [CrossRef]
- Poynton, T.A.; DeFouw, E.R.; Morizio, L.J. A systematic review of online response rates in four counseling journals. J. Couns. Dev. 2019, 97, 33–42. [Google Scholar] [CrossRef]
- Burgard, T.; Bošnjak, M.; Wedderhoff, N. Response rates in online surveys with affective disorder participants. Z. Für Psychologie 2020, 228, 14–24. [Google Scholar] [CrossRef]
- Manfreda, K.L.; Bosnjak, M.; Berzelak, J.; Haas, I.; Vehovar, V. Web surveys versus other survey modes: A meta-analysis comparing response rates. Int. J. Mark. Res. 2008, 50, 79–104. [Google Scholar] [CrossRef]
- Daikeler, J.; Bošnjak, M.; Lozar Manfreda, K. Web versus other survey modes: An updated and extended meta-analysis comparing response rates. J. Surv. Stat. Methodol. 2020, 8, 513–539. [Google Scholar] [CrossRef]
- Daikeler, J.; Silber, H.; Bošnjak, M. A meta-analysis of how country-level factors affect web survey response rates. Int. J. Mark. Res. 2022, 64, 306–333. [Google Scholar] [CrossRef]
- Groves, R.M. Nonresponse rates and nonresponse bias in household surveys. Public Opin. Q. 2006, 70, 646–675. [Google Scholar] [CrossRef]
- Keeter, S.; Miller, C.; Kohut, A.; Groves, R.M.; Presser, S. Consequences of reducing nonresponse in a national telephone survey. Public Opin. Q. 2000, 64, 125–148. [Google Scholar] [CrossRef]
- Fosnacht, K.; Sarraf, S.; Howe, E.; Peck, L.K. How important are high response rates for college surveys? Rev. High. Educ. 2017, 40, 245–265. [Google Scholar] [CrossRef]
- Adekanye, U.O.; Ekiri, A.B.; Galipó, E.; Muhammad, A.B.; Mateus, A.; La Ragione, R.M.; Wakawa, A.; Armson, B.; Mijten, E.; Alafiatayo, R.; et al. Knowledge, attitudes and practices of veterinarians towards antimicrobial resistance and stewardship in Nigeria. Antibiotics 2020, 9, 453. [Google Scholar] [CrossRef] [PubMed]
- Cox, J.A.; Vlieghe, E.; Mendelson, M.; Wertheim, H.; Ndegwa, L.; Villegas, M.V.; Gould, I.; Hara, G.L. Antibiotic stewardship in low-and middle-income countries: The same but different? Clin. Microbiol. Infect. 2017, 23, 812–818. [Google Scholar] [CrossRef] [PubMed]
- Tattevin, P.; Levy Hara, G.; Toumi, A.; Enani, M.; Coombs, G.; Voss, A.; Wertheim, H.; Poda, A.; Daoud, Z.; Laxminarayan, R.; et al. Advocacy for increased international efforts for antimicrobial stewardship actions in low-and middle-Income countries on behalf of alliance for the Prudent Use of Antimicrobials (APUA), under the auspices of the International Society of Antimicrobial Chemotherapy (ISAC). Front. Med. 2020, 7, 503. [Google Scholar]
- Kpokiri, E.E.; Ladva, M.; Dodoo, C.C.; Orman, E.; Aku, T.A.; Mensah, A.; Jato, J.; Mfoafo, K.A.; Folitse, I.; Hutton-Nyameaye, A.; et al. Knowledge, awareness and practice with antimicrobial stewardship programmes among healthcare providers in a Ghanaian tertiary hospital. Antibiotics 2022, 11, 6. [Google Scholar] [CrossRef]
- Kpokiri, E.E.; Taylor, D.G.; Smith, F.J. Development of antimicrobial stewardship programmes in low and middle-income countries: A mixed-methods study in Nigerian hospitals. Antibiotics 2020, 9, 204. [Google Scholar] [CrossRef]
- Anyanwu, M.U.; Okorie-Kanu, O.J.; Anyaoha, C.O.; Kolade, O.A. Veterinary medical students’ perceptions, attitude and knowledge about antibiotic resistance and stewardship: How prepared are our future prescribers? Not. Sci. Biol. 2018, 10, 156–174. [Google Scholar] [CrossRef]
- Odetokun, I.A.; Akpabio, U.; Alhaji, N.B.; Biobaku, K.T.; Oloso, N.O.; Ghali-Mohammed, I.; Biobaku, A.J.; Adetunji, V.O.; Fasina, F.O. Knowledge of antimicrobial resistance among veterinary students and their personal antibiotic use practices: A national cross-sectional survey. Antibiotics 2019, 8, 243. [Google Scholar] [CrossRef]
- Dyar, O.J.; Hills, H.; Seitz, L.T.; Perry, A.; Ashiru-Oredope, D. Assessing the knowledge, attitudes and behaviors of human and animal health students towards antibiotic use and resistance: A pilot cross-sectional study in the UK. Antibiotics 2018, 7, 10. [Google Scholar] [CrossRef]
- Dyar, O.J.; Howard, P.; Nathwani, D.; Pulcini, C. Knowledge, attitudes, and beliefs of French medical students about antibiotic prescribing and resistance. Médecine Et Mal. Infect. 2013, 43, 423–430. [Google Scholar] [CrossRef]
- Kang’ethe, E.K.; Aboge, G.O.; Arimi, S.M.; Kanja, L.W.; Omore, A.O.; McDermott, J.J. Investigation of the risk of consuming marketed milk with antimicrobial residues in Kenya. Food Control. 2005, 16, 349–355. [Google Scholar] [CrossRef]
- Egwuenu, A.; Ejikeme, A.; Tomczyk, S.; von Laer, A.; Ayobami, O.; Odebajo, O.; Akhibi, S.; Agulanna, C.; Osagie, O.; Inweregbu, U.S.; et al. Baseline study for improving diagnostic stewardship at secondary health care facilities in Nigeria. Antimicrob. Resist. Infect. Control. 2022, 11, 65. [Google Scholar] [CrossRef] [PubMed]
- Venne, D.M.; Hartley, D.M.; Malchione, M.D.; Koch, M.; Britto, A.Y.; Goodman, J.L. Review and analysis of the overlapping threats of carbapenem and polymyxin resistant E. coli and Klebsiella in Africa. Antimicrob. Resist. Infect. Control. 2023, 12, 29. [Google Scholar] [CrossRef] [PubMed]
Demographic Characteristics | Response | Frequency (N = 50) | Percentage (%) |
---|---|---|---|
Gender | Female | 14 | 28 |
Male | 36 | 72 | |
Age group | 18–24 years old | 0 | 0 |
25–34 years old | 30 | 60 | |
35–44 years old | 20 | 40 | |
45–54 years old | 0 | 0 | |
55–65 years old | 0 | 0 | |
More than 65 years old | 0 | 0 | |
Highest level of education | AIMLT or FIMLT | 1 | 2 |
BMLS | 35 | 70 | |
Other Bachelor’s degree | 0 | 0 | |
Postgraduate Diploma | 1 | 2 | |
Master’s degree | 12 | 24 | |
Doctorate degree | 1 | 2 | |
Other | 0 | 0 | |
Years registered as a medical laboratory scientist | 0–5 years | 9 | 18 |
6–10 years | 28 | 56 | |
11–15 years | 13 | 26 | |
16–20 years | 0 | 0 | |
21 and above | 0 | 0 | |
Prefer not to say | 0 | 0 | |
Employment status | Private practice | 21 | 42 |
NGO employee | 6 | 12 | |
Government employee | 17 | 34 | |
Research | 0 | 0 | |
Teaching | 4 | 8 | |
Unemployed | 1 | 2 | |
Government contractual | 1 | 2 |
Question | Response | Frequency | Percentage (%) |
---|---|---|---|
Do you regularly perform antibiotics susceptibility testing of microbial isolates? (N = 50) | Yes | 37 | 74 |
No | 3 | 6 | |
Sometimes | 10 | 20 | |
When do you perform antibiotics susceptibility testing of microbial isolates? (N = 49) | It is always performed. | 29 | 59.2 |
It is performed on specific samples. | 14 | 28.6 | |
It is performed only when medical doctors ask for it. | 6 | 12.2 | |
Not performed at all. | 0 | 0 | |
Other. | 0 | 0 | |
Is antimicrobial resistance a problem in your establishment? | Yes | 38 | 76 |
No | 10 | 20 | |
Don’t know | 2 | 4 | |
What are barriers to widespread antibiotics susceptibility testing in your establishment? | High cost of tests | 29 | 58 |
Lack of skilled personnel | 9 | 18 | |
Inadequate laboratory infrastructure | 22 | 44 | |
Limited access to rapid/point-of-care diagnostic tests | 9 | 18 | |
Don’t know | 3 | 6 | |
Other | 4 | 8 |
Question | Response | Frequency | Percentage (%) * |
---|---|---|---|
Is formal training in determining the levels of bacterial resistance to antibiotics available in your establishment? (N = 50) | Yes | 15 | 30 |
No | 33 | 66 | |
Don’t know | 2 | 4 | |
Considering the facilities available in your establishment, which antimicrobial resistance detection method would be most relevant for you to learn? (N = 47) | PCR/Genome-based detection | 25 | 53.2 |
Disc diffusion method | 24 | 51.1 | |
MIC and MBC determination (Dilution or broth method) | 23 | 48.9 | |
Matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) | 6 | 12.8 | |
E-Test | 5 | 10.6 | |
Other | 1 | 2.1 |
Parameters | Response | Frequency | Percentage (%) |
---|---|---|---|
Last antibiotic use (N = 50) | Last month | 22 | 44 |
6 months ago | 10 | 20 | |
In the last year | 7 | 14 | |
More than a year ago | 7 | 14 | |
Can’t remember | 4 | 8 | |
Never | 0 | 0 | |
Did you get a prescription for the antibiotics from a doctor or nurse (N = 50) | Yes | 24 | 48 |
No | 26 | 52 | |
Can’t remember | 0 | 0 | |
When you feel better | 0 | 0 | |
When do you think you should stop taking antibiotics once you have begun treatment? (N = 49) | When you have taken all of the antibiotics as directed by the Doctor or pharmacist | 49 | 100 |
Don’t know | 0 | 0 | |
Other | 0 | 0 | |
It’s okay to buy the same antibiotics, or request these from a doctor, if you’re sick and they helped you get better when you had the same symptoms before (N = 49) | True | 3 | 6.1 |
False | 46 | 93.9 | |
Don’t know | 0 | 0 |
Key Terms | No (%) | Yes (%) |
---|---|---|
Nigeria Centre for Disease Control (NCDC) 5-point action plan for responsible use of antimicrobials | 31 (62) | 19 (38) |
Antibiotic resistance | 2 (4.1) | 47 (95.39) |
Superbugs | 34 (69.4) | 15 (30.6) |
Antimicrobial resistance | 1 (2.1) | 48 (97.9) |
AMR | 18 (36.7) | 31 (63.3) |
Drug resistance | 2 (4.1) | 47 (95.9) |
Antibiotic-resistance bacteria | 3 (6.1) | 46 (93.9) |
Antibiotic stewardship/ antimicrobial stewardship | 34 (65) | 16 (32) |
Question and Type of Information | Response | Frequency | Percentage * (%) |
---|---|---|---|
Which of the following do you think best defines antibiotic stewardship or antimicrobial stewardship? (N = 50) | A systematic effort to educate and persuade prescribers of antibiotics to follow evidence-based prescribing, in order to stem antibiotic overuse, and thus antibiotic resistance. | 2 | 4 |
A coordinated intervention designed to improve and measure the appropriate use of antibiotics by promoting the selection of the optimal antimicrobial drug regimen, dose, duration of therapy and route of administration. | 2 | 4 | |
Optimal selection, dosage, and duration of antibiotic treatment that results in the best clinical outcome for the treatment or prevention of infection, with minimal toxicity to the patient and minimal impact on subsequent resistance | 6 | 12 | |
All of the above | 27 | 54 | |
None of the above | 0 | 0 | |
Don’t know | 13 | 26 | |
Which of the following topics would you like to receive more information on? Resistance to antibiotics | 26 | 52 | |
Guidelines on how to use antibiotics | 22 | 44 | |
Medical conditions for which antibiotics are used | 18 | 36 | |
Prescription of antibiotics | 26 | 52 | |
Critically important antimicrobials | 26 | 52 | |
Resistance to antibiotics and how resistance develops | 33 | 66 | |
Antimicrobial resistance detection methods | 35 | 70 | |
Links between the health of humans, animals and the environment | 27 | 54 | |
Don’t want to receive more information on these issues | 2 | 4 | |
Don’t know | 0 | 0 |
Sources of Information | Frequency | Percentage (%) * |
---|---|---|
A doctor | 33 | 66 |
A nurse | 13 | 26 |
A pharmacy | 38 | 76 |
A hospital or other health care facility | 19 | 38 |
Family or friends | 1 | 2 |
An official health-related website (e.g., a website set up by the national government/public health body) | 31 | 62 |
A health-related website/blog | 15 | 30 |
Online social network | 5 | 10 |
TV | 1 | 2 |
Newspapers/magazines | 3 | 6 |
Radio | 2 | 4 |
Not interested in finding information on antibiotics | 0 | 0 |
Other | 1 | 2 |
Question | Response | Frequency | Percentage (%) * |
---|---|---|---|
Do you believe as a Medical Laboratory Scientist, you have a role to play in preventing public health threats posed by antibiotic resistance? (N = 50) | Yes | 50 | 100 |
No | 0 | 0 | |
At what level do you believe it is most effective to tackle resistance to antibiotics? (N = 50) | At Individual level or within family | 17 | 34 |
At the organisational level | 0 | 0 | |
At state level | 0 | 0 | |
At national level | 0 | 0 | |
At continental level | 0 | 0 | |
At global level | 2 | 4 | |
Action at all levels is needed Don’t know | 31 0 | 62 0 | |
Yes | 36 | 73.5 | |
Do you think antibiotics are widely used in agriculture (including in food-producing animals) in your country? (N = 49) | No | 9 | 18.4 |
Don’t know | 4 | 8.2 |
Variable | Response | Frequency | Percentage (%) |
---|---|---|---|
Antibiotic-resistant infections could make medical procedures like surgery, organ transplants and cancer treatment much more dangerous | True | 44 | 95.7 |
False | 1 | 2.2 | |
I don’t know | 1 | 2.2 | |
Bacteria which are resistant to antibiotics can be spread from one person to the other | True | 42 | 91.3 |
False | 4 | 8.7 | |
I don’t know | 0 | 0 | |
Antibiotic resistance is only a problem for people who take antibiotics regularly | True | 8 | 17.4 |
False | 38 | 82.6 | |
I don’t know | 0 | 0 | |
Antibiotic resistance is an issue that affect other countries, but not here | True | 2 | 4.3 |
False | 44 | 95.7 | |
I don’t know | 0 | 0 | |
Antibiotic resistance is an issue that could affect me or my family | True | 43 | 93.5 |
False | 3 | 6.5 | |
I don’t know | 0 | 0 | |
If bacteria are resistant to antibiotics, it can be very difficult or impossible to treat the infections they cause | True | 45 | 97.8 |
False | 1 | 2.2 | |
I don’t know | 0 | 0 | |
Infections caused by antibiotics resistant bacteria can be very difficult to treat | True | 43 | 95.6 |
False | 2 | 4.4 | |
I don’t know | 0 | 0 | |
Many infections are becoming increasingly resistant to treatment by antibiotics | True | 43 | 95.6 |
False | 1 | 2.2 | |
I don’t know | 1 | 2.2 | |
Antibiotic resistance occurs when your body becomes resistant to antibiotics and they no longer work as well | True | 33 | 70.2 |
False | 14 | 29.8 | |
I don’t know | 0 | 0 | |
Healthy people and animals can carry antibiotic resistant bacteria | Agree | 40 | 86.9 |
Disagree | 5 | 10.9 | |
I don’t know | 1 | 2.2 | |
Prophylactic antibiotics are an appropriate alternative to protect animal health | Agree | 19 | 41.3 |
Disagree | 19 | 41.3 | |
I don’t know | 8 | 17.4 | |
Farmers should give fewer antibiotics to food-producing animals | Agree | 26 | 56.5 |
Disagree | 11 | 23.9 | |
I don’t know | 9 | 19.6 | |
Inappropriate use of antibiotics in animals can result in negative impact on human health | Agree | 39 | 84.8 |
Disagree | 5 | 10.9 | |
I don’t know | 2 | 4.3 | |
People should use antibiotics only when they are prescribed by a doctor or nurse | Agree | 40 | 87 |
Disagree | 6 | 13 | |
I don’t know | 0 | 0 | |
People should not keep antibiotics and use them later for other illnesses | Agree | 46 | 100 |
Disagree | 0 | 0 | |
I don’t know | 0 | 0 | |
Doctors should only prescribe antibiotics when they are needed | Agree | 45 | 97.8 |
Disagree | 1 | 2.2 | |
I don’t know | 0 | 0 | |
Everyone needs to take responsibility for using antibiotics responsibly | Agree | 46 | 100 |
Disagree | 0 | 0 | |
I don’t know | 0 | 0 | |
I am not at risk of getting an antibiotic resistant infection, as long as I take my antibiotics correctly. | Agree | 31 | 67.4 |
Disagree | 14 | 30.4 | |
I don’t know | 1 | 2.2 | |
Antibiotics kill viruses | Agree | 2 | 4.3 |
Disagree | 41 | 91.4 | |
I don’t know | 2 | 4.3 | |
Antibiotics are effective in the treatment of cold or flu | Agree | 14 | 30.4 |
Disagree | 29 | 63 | |
I don’t know | 3 | 6.5 | |
Overuse of antibiotics makes them become ineffective | Agree | 37 | 80.4 |
Disagree | 7 | 15.2 | |
I don’t know | 2 | 4.3 | |
A withdrawal period has to be strictly observed in treated poultry before any poultry product is passed as fit for human consumption | Agree | 41 | 89.1 |
Disagree | 1 | 2.2 | |
I don’t know | 4 | 8.7 | |
A withdrawal period does not have to be observed for milking cows treated with antibiotics such as penicillin before milk can be consumed | Agree | 8 | 17.4 |
Disagree | 31 | 67.4 | |
I don’t know | 7 | 15.2 | |
Pharmaceutical companies should develop new antibiotics | Agree | 38 | 80.9 |
Disagree | 7 | 14.9 | |
I don’t know | 2 | 4.3 |
Knowledge Status | Frequency (N = 46) | Percentage (%) |
---|---|---|
Good knowledge | 30 | 65.2 |
Poor Knowledge | 16 | 34.8 |
Variable | Knowledge Status Good Poor | Chis Square (χ2) | p-Value |
---|---|---|---|
Age | 0.640 | 0.533 | |
25–34 | 17 (60.7%) 11 (39.3%) | ||
35–44 | 13 (72.2%) 5 (27.8%) | ||
Gender | 4.436 | 0.048 * | |
Male | 24 (75%) 8 (25%) | ||
Female | 6 (42.9%) 8 (57.1%) | ||
Education level | 0.359 | 0.722 | |
Master’s degree | 8 (72.7%) 3 (27.3%) | ||
Lower education Level (including BMLS, AIMLT or FIMLT, and PgD) | 22 (62.9%) 13 (37.9%) | ||
Post-qualification experience | 0.360 | 0.835 | |
0–5 years | 5 (62.5%) 3 (37.5%) | ||
6–10 years | 17 (63.0%) 10 (37.0%) | ||
11–15 years | 8 (72.7%) 3 (27.3%) |
Variable | Knowledge Status Good (%) Poor (%) | OR | 95% CI | p-Value |
---|---|---|---|---|
Age | ||||
25–34 | 17 (60.7) 11 (39.3) | 1.00 | ||
35–44 | 13 (72.2) 5 (27.8) | 0.74 | 0.16–3.41 | 0.697 |
Gender | ||||
Male | 24 (75) 8 (25) | 2.81 | ||
Female | 6 (42.9) 8 (57.1) | 1.00 | 0.73–10.86 | 0.134 |
Education level | ||||
Lower education (including BMLS, AIMLT or FIMLT, and PgD) | 22 (62.9) 13 (37.9) | 1.00 | ||
Master’s degree | 8 (72.7) 3 (27.3) | 1.69 | 0.33–8.61 | 0.527 |
Post-qualification experience | ||||
0–5 years | 5 (62.5) 3 (37.5) | 1.00 | 0.16–4.97 | 0.882 |
6–10 years | 17 (63.0) 10 (37.0) | 0.88 | 0.14–15.98 | 0.751 |
11–15 years | 8 (72.7) 3 (27.3) | 1.47 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Huang, S.; Eze, U.A. Awareness and Knowledge of Antimicrobial Resistance, Antimicrobial Stewardship and Barriers to Implementing Antimicrobial Susceptibility Testing among Medical Laboratory Scientists in Nigeria: A Cross-Sectional Study. Antibiotics 2023, 12, 815. https://doi.org/10.3390/antibiotics12050815
Huang S, Eze UA. Awareness and Knowledge of Antimicrobial Resistance, Antimicrobial Stewardship and Barriers to Implementing Antimicrobial Susceptibility Testing among Medical Laboratory Scientists in Nigeria: A Cross-Sectional Study. Antibiotics. 2023; 12(5):815. https://doi.org/10.3390/antibiotics12050815
Chicago/Turabian StyleHuang, Sheng, and Ukpai A. Eze. 2023. "Awareness and Knowledge of Antimicrobial Resistance, Antimicrobial Stewardship and Barriers to Implementing Antimicrobial Susceptibility Testing among Medical Laboratory Scientists in Nigeria: A Cross-Sectional Study" Antibiotics 12, no. 5: 815. https://doi.org/10.3390/antibiotics12050815
APA StyleHuang, S., & Eze, U. A. (2023). Awareness and Knowledge of Antimicrobial Resistance, Antimicrobial Stewardship and Barriers to Implementing Antimicrobial Susceptibility Testing among Medical Laboratory Scientists in Nigeria: A Cross-Sectional Study. Antibiotics, 12(5), 815. https://doi.org/10.3390/antibiotics12050815